z-logo
open-access-imgOpen Access
Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
Author(s) -
Matsutani Masako,
Imai Yasutomo,
Inoue Yukako,
Hosotani Yuka,
Kusakabe Minori,
Natsuaki Masaru,
Yamanishi Kiyofumi
Publication year - 2020
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12099
Subject(s) - dupilumab , atopic dermatitis , dermatology , medicine
Dupilumab was effective for 53 patients with moderate‐to‐severe AD in our daily practice. TARC reduction, however, did not necessarily reflect improved AD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here